Bausch Health Companies (BHC) Gross Margin (2009 - 2026)
Bausch Health Companies (BHC) reported Gross Margin of 100.0% for Q1 2026, up 4.0% on a YoY basis from 96.15% in Q1 2025, and little changed sequentially from 100.14% in Q4 2025.
Bausch Health Companies (BHC) Gross Margin (2009 - 2026) Analysis & Trends
Bausch Health Companies (BHC) has 18 years of Gross Margin data on file, last reported at 100.0% in Q1 2026.
- For the quarter ending Q1 2026, Gross Margin rose 4.0% year-over-year to 100.0%; the trailing twelve-month figure through Mar 2026 stood at 99.59% (up 1.0% YoY), and the FY2025 full-year result was 100.0%, changed 0.0% from the prior year.
- Gross Margin was little changed at 100.0% in Q1 2026, from 100.14% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 174.65% in Q4 2022 to a low of 70.47% in Q2 2023.
- A 5-year average of 94.2% and a median of 99.48% in 2025 frame the typical range for Gross Margin.
- Across the five-year window, Gross Margin soared 5119 bps in 2022 and tumbled 7340 bps in 2023, its largest moves.
- Tracing BHC's Gross Margin over 5 years: stood at 174.65% in 2022, then sank by 42 bps to 101.25% in 2023, then grew by 2 bps to 102.85% in 2024, then fell by 3 bps to 100.14% in 2025, then declined by 0 bps to 100.0% in 2026.
- Business Quant data shows BHC's Gross Margin at 100.0% in Q1 2026, 100.14% in Q4 2025, and 99.48% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 49.52% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 71.66% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 62.93% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 82.93% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 32.97% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 98.31% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.26% |
| 10 | Bausch Health Companies | 1.66 Bn | 1.33 Bn | 2.52 Bn | 100.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100.00% |
| Dec 31, 2025 | 100.14% |
| Sep 30, 2025 | 99.48% |
| Jun 30, 2025 | 98.70% |
| Mar 31, 2025 | 99.96% |
| Dec 31, 2024 | 102.85% |
| Sep 30, 2024 | 95.50% |
| Jun 30, 2024 | 100.00% |
| Mar 31, 2024 | 100.00% |
| Dec 31, 2023 | 101.25% |
| Sep 30, 2023 | 72.65% |
| Jun 30, 2023 | 70.47% |
| Mar 31, 2023 | 70.58% |
| Dec 31, 2022 | 174.65% |
| Sep 30, 2022 | 71.99% |
| Jun 30, 2022 | 71.12% |
| Mar 31, 2022 | 72.05% |
| Dec 31, 2021 | 123.45% |
| Sep 30, 2021 | 72.81% |
| Jun 30, 2021 | 99.62% |